F. Icli Et Al. , "Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric," JOURNAL OF SURGICAL ONCOLOGY , vol.64, no.4, pp.318-323, 1997
Icli, F. Et Al. 1997. Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric. JOURNAL OF SURGICAL ONCOLOGY , vol.64, no.4 , 318-323.
Icli, F., Karaoguz, H., AKBULUT, H., Dincol, D., DEMİRKAZIK, A., & Cay, F., (1997). Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric. JOURNAL OF SURGICAL ONCOLOGY , vol.64, no.4, 318-323.
Icli, F Et Al. "Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric," JOURNAL OF SURGICAL ONCOLOGY , vol.64, no.4, 318-323, 1997
Icli, F Et Al. "Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric." JOURNAL OF SURGICAL ONCOLOGY , vol.64, no.4, pp.318-323, 1997
Icli, F. Et Al. (1997) . "Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric." JOURNAL OF SURGICAL ONCOLOGY , vol.64, no.4, pp.318-323.
@article{article, author={F Icli Et Al. }, title={Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric}, journal={JOURNAL OF SURGICAL ONCOLOGY}, year=1997, pages={318-323} }